Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.
about
Functional imaging of interleukin 1 beta expression in inflammatory process using bioluminescence imaging in transgenic miceEfficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.Pharmacotherapy for allergic contact dermatitis.Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.Fexofenadine Suppresses Delayed-Type Hypersensitivity in the Murine Model of Palladium Allergy.A Role of Staphyococcus aureus, Interleukin-18, Nerve Growth Factor and Semaphorin 3A, an Axon Guidance Molecule, in Pathogenesis and Treatment of Atopic Dermatitis.Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice.Translational Animal Models of Atopic Dermatitis for Preclinical Studies.
P2860
Q33361075-FC9573E7-7C1B-4D6A-8ACD-E621CBE8A4E8Q35167249-9B265117-965B-4954-B72E-78F655CA348DQ36979315-97714585-8217-4593-A90D-027095819A0BQ37716013-AACD4977-AD12-4F5C-928B-5B315E162E55Q41181359-DDA2BE06-5448-4B6B-ADAF-851DE0F063BDQ42025423-81E18E6F-FD56-4D32-A0DB-641665C8C05EQ42168425-9F3ED640-3A5E-4BA2-9451-D4261A741AA5Q53257382-27FE4B9F-AEA2-4192-BA91-40BD81ED1BE0
P2860
Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@ast
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@en
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@nl
type
label
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@ast
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@en
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@nl
prefLabel
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@ast
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@en
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@nl
P2093
P2860
P1476
Olopatadine hydrochloride supp ...... onic contact hypersensitivity.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2222.2005.02147.X
P577
2005-01-01T00:00:00Z